跳至主要内容
临床试验/IRCT20240129060837N1
IRCT20240129060837N1招募中3 期

Efficacy of L-carnitine in decrease of liver enzymes and liver fat content in patients with non-alcoholic fatty liver disease

Ahvaz University of Medical Sciences0 个研究点目标入组 102 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
招募中
入组人数
102

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
15 years 至 no limit(—)
性别
All

入选标准

  • AST, ALT levels above the normal range
  • Sonographic findings consistent with fatty liver
  • No history of viral hepatitis or conditions such as hemochromatosis, Wilson’s disease, autoimmune hepatitis, alpha-1 antitrypsin deficiency or chronic liver disease

排除标准

  • Significant alcohol consumption (more than 10 grams per day for women and more than 20 grams per day for men)
  • Pregnant or breastfeeding women

研究者

相似试验